-1.02%
Today
Loading 1D prices…
Company profile
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Sector
Industrials
Industry
Industrial Instruments For Measurement, Display, and Control
Exchange
Nasdaq
Display currency
USD
Location
Germantown, MD, United States
Employees
130
Fiscal year end
1231
CIK
1616543
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| MLABMesa Laboratories Inc. Common Stock | $676.4M | $249.1M | +2.69% | $1.21 | -0.03% | Hold |
| HURCHurco Companies Inc. Common Stock | $141.1M | $137.8M | -2.56% | -$0.55 | -3.54% | Unrated |
| SYPRSypris Solutions Inc. Common Stock | $43.3M | $119.9M | -0.01% | -$0.28 | +2.17% | Unrated |
| STSensata Technologies Holding plc Ordinary Shares | $6.4B | $3.7B | +0.84% | $0.21 | +3.44% | Hold |
| RALRalliant Corporation Common Stock | $7.4B | $2.1B | -59.12% | -$10.84 | +4.13% | Buy |